Lucemyra

Bausch Health headquarters formerly Valeant

Marketing

Salix inks deal with Dova, 3rd recent deal to boost portfolio

Salix's latest deal not only beefs up its own portfolio, but gives Dova a co-promo boost for its newly minted chronic liver disease drug, Doptelet.

Beth Snyder Bulik Oct 5, 2018 11:03am

US WorldMeds Lucemyra product shot

Salix, US WorldMeds dial in Lucemyra launch

Aug 13, 2018 9:30am

valeant

Valeant signs on to hawk opioid withdrawal drug Lucemyra

Jun 28, 2018 10:54am